Clinical model of a patient with non-severe mycoplasmal and pneumococcal community-acquired pneumonia
156 patients with non-severe community-acquired pneumonia (CAP) of pneumococcal (124) and mycoplasmal (32) etiology underwent the analysis of initial clinical implications of the disease. A clinical model of a patient with mycoplasmal and pneumococcal community-acquired pneumonia was developed. Its purpose is optimization of starting empiric antibacterial therapy of community-acquired pneumonia within the regimen of antibacterial mono-therapy.